These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. What are the predictors of post-ERCP pancreatitis, and how useful are they? Sultan S, Baillie J. JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185 [Abstract] [Full Text] [Related]
10. Serum Serine Peptidase Inhibitor Kazal-Type 1, Trypsinogens 1 to 3, and Complex of Trypsin 2 and α1-Antitrypsin in the Diagnosis of Severe Acute Pancreatitis. Rainio M, Lindström O, Penttilä A, Itkonen O, Kemppainen E, Stenman UH, Kylänpää L. Pancreas; 2019 Mar; 48(3):374-380. PubMed ID: 30747826 [Abstract] [Full Text] [Related]
11. Trypsin-alpha 1-protease inhibitor complexes in serum and clinical course of acute pancreatitis. Borgström A, Lasson A. Scand J Gastroenterol; 1984 Nov; 19(8):1119-22. PubMed ID: 6085419 [Abstract] [Full Text] [Related]
12. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis. Kobayashi K, Sasaki T, Serikawa M, Inoue M, Itsuki H, Chayama K. Pancreas; 2011 Nov; 40(8):1206-10. PubMed ID: 21792081 [Abstract] [Full Text] [Related]
13. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Hedström J, Haglund C, Haapiainen R, Stenman UH. Int J Cancer; 1996 May 03; 66(3):326-31. PubMed ID: 8621252 [Abstract] [Full Text] [Related]